TB / MDR TB Project

TB / MDR TB Project

Jeudi, 25 Avril 2013 00:00

Videomessage from Valentina Sarkisova (Russia)

International Hospital Federation (IHF)

The Lilly MDR-TB Partnership was created in 2003 to combat multidrug-resistant tuberculosis (MDR-TB). The International Hospital Federation has been a member of the project since 2004.

The IHF bilateral partnership was created in 2004 upon recognition of the need, firstly, to address TB management/treatment from the perspective of the hospital/healthcare setting.

Secondly, and even more importantly, upon acknowledgment that 'ignorance' and exclusion of IHF membership group, may have led and can lead to adoption and implementation of contra-productive decisions and actions in the fight against MDR-TB.

Lundi, 06 Décembre 2010 14:17

[HIFA2015] World TB Day

In a message released today, 24 March 2009, on the occasion of World TB Day, Dr. Luis Sambo, Regional Director of the World Health Organization Regional Office for Africa has called for the "rigorous implementation of the STOP TB Strategy, including universal coverage with DOTS (the Directly Observed Treatment Short-Course)" in order to significantly improve case detection and treatment outcomes.

He said that the most important element of DOTS is a regimen consisting of a combination of first-line drugs taken, ideally, under direct observation of a health care worker. The combination is known to be very effective against active drug-susceptible TB as long as patients are compliant and complete the entire six-to-eight month course.

"We must endeavour to put every single patient on quality TB Treatment and strive to minimize patient transfers, defaults and deaths", the Regional Director said.

International Union Against Tuberculosis and Lung Disease (UNION)

Despite recent progress, tuberculosis (TB) remains an important global public health problem. One-third of the world's population is currently infected with the tubercle bacillus that causes TB; and, according to the World Health Organization (WHO), there were 9.4 million new cases and 1.7 million deaths from TB in 2009.

Although TB is curable, inadequate TB control is one of the factors that has led to an increase in multidrug-resistant tuberculosis (MDR-TB), a particularly dangerous form of the disease, which is potentially incurable in many settings. MDR-TB is defined as disease caused by TB bacilli resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs. Rates of MDR-TB are high in some countries and, coupled with the devastating effects of TB/HIV co-infection, threaten to undermine TB control efforts worldwide.

The Union has been a leader in tuberculosis prevention, control and treatment since it was founded in 1920 as the International Union Against Tuberculosis. It is mostly widely known for the research that led to the directly observed treatment, short course (DOTS) strategy, endorsed by the WHO and used to treat more than 37 million TB patients around the world.

Nomination form "Leading Lights"

Nomination form

“Leading Lights” initiative for ICN TB Project

The “Leading Lights” award recognises outstanding contribution to the care of people affected by TB.

Eligibility: the nominee must be nurse or health care worker who

  • Is directly involved with caring for those affected by TB
  • Has received training as part of the ICN TB Project since 2005 either during a full TB workshop or from someone who has been trained by the project to train others

Who can nominate someone as a ‘Leading Light’?

  •  An individual can nominate themselves but has to provide the contact details of someone who can verify the information provided
  • Anyone can nominate another person who meets the criteria

Nominee

Reason for nomination or details of Performance

Please describe the special aspect of your/the nominee’s work you wish to highlight (max 500words)

A suggestion of the format of this description would be :

  1. The issue you/he/she wanted to tackle and why – what was the problem?
  2. What did you/he/she decide to do?
  3. How did you/he/she do it and who else was involved?
  4. Which ICN tools or materials did you/he/she find most helpful?
  5. What was the result of your/her/his efforts?
  6. How you feel things improved for yourself/the nominee, your/his/her colleagues and most importantly for patients?

Activities since training can also include : other people trained, impact on patient and/or project outcomes, changes made to practice, changes made to the environment, challenges faced, things that helped.

Any numbers are welcome.

If nominating yourself give the name and contact details of a referee.

Jeudi, 17 Mars 2011 16:32

2011 TB Award Recipients

  Fifteen Nurses receive the 5th ICN/Lilly Award 

 for Work in Tuberculosis and Multi-drug Resistant TB

The ICN/Lilly Award for Nursing Excellence in TB/MDR-TB is one aspect of ICN’s work in TB and multi-drug resistant TB as a founding member of the Lilly MDR-TB Partnership. During this partnership, since 2005 more than 30'000 nurses and allied health workers have been trained in TB endemic countries. This annual award supported by Lilly recognizes nursing expertise and aims to motivate nurses working with those affected by TB and MDR-TB in countries included in the TB project. It showcases the contribution made by nurses to TB prevention, care and treatment and offers the recipients an educational grant to continue their professional development along with a specially designed medal. Recipients are selected by their national nurses association for their outstanding achievement in TB prevention, care and treatment.

On 24 March, on the occasion of  World TB Day, the International Council of Nurses in partnership with Eli Lilly and Company has given awards to the following fifteen nurses, from eleven countries, who through their dedication, passion and innovative care strategies, are living examples of the World TB Day slogan "On the move against tuberculosis: Transforming the fight towards elimination". 

 

Page 4 sur 17